FDA Office of Minority Health Lecture Series: “Precision Cardiovascular Medicine for Multi-ethnic Populations”
Date: Thursday, February 23, 2017
Time: 11-12 PM
Location: Webinar
Time: 11-12 PM
Location: Webinar
Description:
In honor of American Heart Month, the FDA Office of Minority Health will host a one hour webinar featuring Dr. Manrai from Harvard University. During this time, Dr. Manrai will update us on his current research on genetic misdiagnoses related to cardiomyopathy using a health disparities framework.
In honor of American Heart Month, the FDA Office of Minority Health will host a one hour webinar featuring Dr. Manrai from Harvard University. During this time, Dr. Manrai will update us on his current research on genetic misdiagnoses related to cardiomyopathy using a health disparities framework.
During this webinar you will learn more about::
- contemporary uses of genetic testing for the inherited heart disease hypertrophic cardiomyopathy (HCM)
- the consequences of a lack of diverse control sequence data on variant classifications and
- the value of the current pathogenicity-based scale of rating clinical-grade genetic variation.
Speaker:
Dr. Arjun Manrai
Researcher, Harvard Medical School
Department of Biomedical Informatics
Dr. Arjun Manrai
Researcher, Harvard Medical School
Department of Biomedical Informatics
Biography:
Arjun (Raj) Manrai is a researcher at the Department of Biomedical Informatics at Harvard Medical School. Manrai received his undergraduate degree in Physics from Harvard College and completed his Ph.D. in Bioinformatics and Integrative Genomics under the supervision of Professor Isaac Kohane at the Harvard-MIT Division of Health Sciences and Technology. Manrai is broadly interested in the opportunities and challenges of using genomic data in the clinic. His research draws on theoretical and computational developments in statistical genetics, machine learning, and scientific reproducibility to advance the clinical utility of genetic discoveries. His work has been published in the New England Journal of Medicine and JAMA, and featured in the Wall Street Journal, New York Times, and NPR. Manrai is especially interested in developing quantitative methods and computational resources that translate findings in genomic medicine to benefit underserved communities.
Arjun (Raj) Manrai is a researcher at the Department of Biomedical Informatics at Harvard Medical School. Manrai received his undergraduate degree in Physics from Harvard College and completed his Ph.D. in Bioinformatics and Integrative Genomics under the supervision of Professor Isaac Kohane at the Harvard-MIT Division of Health Sciences and Technology. Manrai is broadly interested in the opportunities and challenges of using genomic data in the clinic. His research draws on theoretical and computational developments in statistical genetics, machine learning, and scientific reproducibility to advance the clinical utility of genetic discoveries. His work has been published in the New England Journal of Medicine and JAMA, and featured in the Wall Street Journal, New York Times, and NPR. Manrai is especially interested in developing quantitative methods and computational resources that translate findings in genomic medicine to benefit underserved communities.
Registration to attend via remote access:
Instructions:
FDA Staff
FTE’s please select the following link:
FTE’s please select the following link:
-OR-
* Go to the AMS website at https://iam.hhs.gov and log-in. If you are a first time AMS user, select "AMS First Time User?" or use your PIV card to login.
* Under Catalog Search, click Advanced Search.
* Under Advanced Search, leave ALL fields blank except for the Start Date, ID field and the Delivery Type field.
* In the Start Date choose: 2/23/2017
* In the ID field enter the Offering ID number: 155577
* In the Delivery Type field select ALL.
* Click the Search button on the right.
* The next screen provides the Offering title and information.
* Under the Offering information on the left, select Register.
* A new window will appear the Registration confirmation information. Offering is listed under In-Progress Learning.
If you have any difficulty logging into the LMS, please contact the LMS Help Desk at 301-827-3742 or 1-888 807-3742; itcallcenter@fda.gov
If you cannot locate the offering in the LMS, please contact: Marcy Wexler, marcy.wexler@fda.hhs.gov
FDA Contractors
For individuals unable to register with AMS (e.g., ORISE fellows), please contact Marcy Wexler, marcy.wexler@fda.hhs.gov for registration.
For individuals unable to register with AMS (e.g., ORISE fellows), please contact Marcy Wexler, marcy.wexler@fda.hhs.gov for registration.
Non-FDA Staff
Register here: https://www.eventbrite.com/e/
Register here: https://www.eventbrite.com/e/
Reasonable Accommodations
The FDA provides reasonable accommodations for all individuals with disabilities who apply for training or developmental opportunities. If you need a reasonable accommodation for any part of the training application process please notify the training contact for this particular event. Reasonable accommodation requests are granted on a case-by case basis. Should you need sign language interpretation to attend this event, please send the request to Interpreting.Services@oc.fda.
The FDA provides reasonable accommodations for all individuals with disabilities who apply for training or developmental opportunities. If you need a reasonable accommodation for any part of the training application process please notify the training contact for this particular event. Reasonable accommodation requests are granted on a case-by case basis. Should you need sign language interpretation to attend this event, please send the request to Interpreting.Services@oc.fda.
References:
If you have questions concerning this program, please contact Marcy Wexler, marcy.wexler@fda.hhs.gov.
Helene D. Clayton-Jeter, O.D.
Office of Health and Constituent Affairs
Food and Drug Administration
Office of Health and Constituent Affairs
Food and Drug Administration
For more information about the Cardiovascular & Endocrine Liaison Program visit the FDA Patient Network
No hay comentarios:
Publicar un comentario